argenx SE reported $36M in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
AstraZeneca USD 28.8B 2.79B Sep/2026
Genmab DKK 4.96B 28M Jun/2026
GlaxoSmithKline GBP 21.7B 7.75B Sep/2026
GRIFOLS EUR 8.69B 1.52B Sep/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Lakefront Biotherapeutics EUR 1.83M 2.94M Sep/2026
Qiagen NV USD 1.63B 19.45M Jun/2026
UCB EUR 2.18B 634M Dec/2025